MAY 30, 2018 02:36 AM PDT

Treating Chemotherapy-Induced Pain

WRITTEN BY: Nouran Amin

Recent research has studied the effects of a protein, called apolipoprotein A-I binding protein (AIBP), in mice with chemotherapy-induced pain. It is a new approach that may be effective for patients suffering from chemotherapy-induced pain as well as an alternative to opiate

The research study was led by the University of California (UC) San Diego in La Jolla and published in the journal Cell Reports. The report describes how one spinal injection of AIBP reduced chemotherapy-induced pain in mice without any apparent side effects. AIBP works by binding to a cell surface protein known as toll-like receptor 4 (TLR4) which plays a crucial part in infection recognition and immune system activation.

The investigators found that AIPB turned off the mice's TLR4 receptors, ultimately inhibiting and reversing inflammation and cell processes involved in pain sensation. "What's so special," says study author Tony L. Yaksh, who is a professor in the Department of Anesthesiology at UC San Diego School of Medicine, "about our new approach, inhibiting the TLR4 receptor with AIBP, is that it actually modifies the pain processing systems themselves."

Pain is an unfortunate consequence of cancer treatment that can disable the overall quality of life, such as reducing job opportunities and impairing psychological health. A common side effect of chemotherapy is a persistent, ongoing painful condition that destroys the nerves so that even the "lightest touch" can lead to painful sensations. Cancer survivors may also have pain as a result of radiotherapy and surgery. In fact, Prof. Yaksh says that 39 percent of the 1.7 million people in the U.S. diagnosed with cancer annually experience pain as a result of cancer or the cancer treatment.

Investigators are already working on alternative options to administer AIBP systemically. However, they believe that many individuals would rather have an injection in their spine "every few months" than live with persistent pain and painful sensations. More so ever, a crucial implication is that AIBP could be created as an alternative to high-dose morphine for those suffering with "unremitting severe pain"; as this will successfully reduce the use of opioids and opiod misuse. However, Prof. Yaksh notes that regardless opiates should never be dropped out of the treatment plan for persistent pain; "that would be a tragedy," he explains.

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 21, 2018
Drug Discovery
NOV 21, 2018
Drug Could Seek New Approach For Autoimmunity
From a failed pain drug, a protein called ‘BH4’, was recently discovered to have surprising implications in the treatment of autoimmunity and c...
NOV 25, 2018
Drug Discovery
NOV 25, 2018
Advancing Drug Therapies for an Increasing Case of a Parasitic infection Among Displaced Syrians
Cases of Cutaneous leishmaniasis (CL), a parasitic disease, has increased dramatically in Syria and neighboring countries as a result of the conflict-relat...
DEC 17, 2018
Health & Medicine
DEC 17, 2018
Light Makes An Itch Go Away!
EMBL researchers have now found a way to stop itch with light in mice. Nature Biomedical Engineering publishes their results on 17 December 2018....
JAN 15, 2019
Immunology
JAN 15, 2019
A Possible Key to Severe Flu
By studying the impact that NPY and its receptor Y1R have on influenza in mice, the research group has now discovered that NPY produced in lung phagocytes can aggravate influenza....
JAN 17, 2019
Microbiology
JAN 17, 2019
Ulcerative Colitis Relieved by Fecal Microbiota Transplant
The community of microbes in our gut is critical to our health. If it's out of balance, researchers are investigating whether 'healthy' fecal material can restore it....
FEB 08, 2019
Drug Discovery
FEB 08, 2019
Drug Combination Generates New Neurons from Neighboring Cells
In a study published in Stem Cell Reports, scientists at Penn State University have developed a drug cocktail that converts neighboring cells—often k...
Loading Comments...